• Exchange: Helsinki
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ORNAV:FH

30.1400 EUR 0.2900 0.97%

As of 11:29:59 ET on 09/22/2014.

Snapshot for Orion OYJ (ORNAV)

Open: 29.5600 Day's Range: 29.5600 - 30.1800 Volume: 16,278
Previous Close: 29.8500 52wk Range: 17.9000 - 30.1800 1-Yr Rtn: +77.87%

Stock Chart for ORNAV

No chart data available.
  • ORNAV:FH 30.1400
  • 1D
  • 1M
  • 1Y
29.8500
Interactive ORNAV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ORNAV

Current P/E Ratio (ttm) 20.6438
Estimated P/E(12/2014) 20.1067
Relative P/E vs. HEXP 0.7649
Earnings Per Share (EUR) (ttm) 1.4600
Est. EPS (EUR) (12/2014) 1.4990
Est. PEG Ratio -
Market Cap (M EUR) 4,266.54
Shares Outstanding (M) 40.96
30 Day Average Volume 12,025
Price/Book (mrq) 8.2443
Price/Sale (ttm) 4.2208
Dividend Indicated Gross Yield 4.15%
Cash Dividend (EUR) 1.2500
Dividend Ex-Date 03/26/2014
5 Year Dividend Growth 5.64%
Next Earnings Announcement 10/22/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ORNAV

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for ORNAV

Orion Oyj develops and manufactures pharmaceuticals and diagnostic kits. The Company produces hormone therapies and drugs to treat central nervous system disorders, cardiovascular diseases and urological disorders, and in vitro diagnostic kits used in doctor's offices and small laboratories.

Hannu SyrjaenenChairmanJukka YlppoVice Chairman
Timo LappalainenPresident/CEOJari KarlsonChief Financial Officer
More Company Profile & Key Executives for ORNAV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil